Blah M, Caremel R, Sibert L, Bugel H, Grise P
Service d'urologie, CHU Charles-Nicolle, 1, rue de Germont, 76031 Rouen, France.
Prog Urol. 2008 Feb;18(2):114-9. doi: 10.1016/j.purol.2007.12.005. Epub 2008 Mar 17.
The aims of this study are to describe the implantation technique of an artificial urinary sphincter (AUS) with intracavernous cuff, define the indications and report the preliminary results of this technique.
A single-centre retrospective study was carried out in 10 patients with a median age of 66 years. The aetiology of urinary incontinence was radical prostatectomy alone in four cases, combined with radiotherapy in four cases and transurethral resection of the prostate in two cases. The initial treatment consisted of AUS in seven cases and suburethral tape in two cases and the last patient had not been previously treated. Failure of AUS was due to atrophy in three cases and urethral erosion in four cases. Six patients needed to use more than three pads per day. Erections were absent in all patients. All patients were treated by insertion of an intracavernous cuff according to the same technique: perineoscrotal incision on the median raphe, dissection of the bulbar urethra and inferior aspect of the corpora cavernosa, vertical incision of the tunica albuginea on either side of the urethra, passage of the cuff from one incision to the other behind the tunica albuginea and leaving the tunica albuginea against the urethra, and closure of the tunica albuginea by interrupted sutures leaving a passage for the cuff. The median follow-up was 15.5 months.
The median operating time was 90 min. No intraoperative complication was observed. Two patients had to be explanted because of infection of the material. Seven of the remaining eight patients were satisfied and six of them needed less than one pad per day. A history pelvic irradiation did not appear to have any impact on the results.
The treatment of male urinary incontinence by artificial urinary sphincter with intracavernous cuff is a simple technique that improves the trophicity and calibre of the urethra underneath the cuff. This technique achieved good results in patients with a history of pelvic irradiation.
本研究旨在描述带海绵体内袖套的人工尿道括约肌(AUS)植入技术,明确其适应证,并报告该技术的初步结果。
对10例患者进行单中心回顾性研究,患者中位年龄为66岁。尿失禁病因包括单纯根治性前列腺切除术4例、联合放疗4例、经尿道前列腺切除术2例。初始治疗中,7例采用AUS,2例采用尿道下吊带,最后1例患者此前未接受过治疗。AUS失败的原因包括3例萎缩和4例尿道侵蚀。6例患者每天需要使用超过3片尿垫。所有患者均无勃起功能。所有患者均按照相同技术插入海绵体内袖套进行治疗:在阴囊中缝处行会阴阴囊切口,解剖球部尿道及海绵体下表面,在尿道两侧纵行切开白膜,将袖套从一个切口穿过白膜后方至另一个切口,并使白膜贴合尿道,然后间断缝合白膜,为袖套留出通道。中位随访时间为15.5个月。
中位手术时间为90分钟。未观察到术中并发症。2例患者因材料感染不得不取出装置。其余8例患者中有7例满意,其中6例患者每天需要使用少于1片尿垫。既往盆腔放疗史似乎对结果无任何影响。
采用带海绵体内袖套的人工尿道括约肌治疗男性尿失禁是一种简单的技术,可改善袖套下方尿道的营养状况和管径。该技术在有盆腔放疗史的患者中取得了良好效果。